 |
| Asthma Resources
|
|
 |
|
|
| The following patient resources provide useful information about
childhood asthma.
|
|
|
| Asthma and Allergy Foundation of America (AAFA) |
|
1233 20th Street, N.W., Suite 402, Washington, DC 20036
Phone: 202-466-7643
Fax: 202-466-8940 |
| www.aafa.org |
|
| The AAFA patient-friendly web site provides helpful information about both asthma and allergies. Their "Ask the Allergist" link allows you to email questions about asthma
and allergies to an actual doctor. Their toll-free hotline (1-800-7-ASTHMA or 1-800-727-8462) is another resource. |
|
|
| Allergy and Asthma Network/Mothers of Asthmatics, Inc. (AANMA)
|
|
2751 Prosperity Avenue, Suite 150, Fairfax, VA 22031
Phone: 703-641-9595
Fax: 703-573-7794 |
| www.aanma.org |
|
| Since 1985, AANMA has worked to help families in their quest to overcome and maintain control over asthma, allergies, and related conditions, through education. The AANMA web site includes Breatherville, USA™, which is another resource for learning about asthma and allergies and how to minimize symptoms. The Play Time section of Breatherville has games and links just for kids. |
|
|
American Lung Association® (ALA)
|
|
|
61 Broadway, 6th Floor, New York, NY 10006 |
|
Phone: 212-315-8700 |
|
Local chapters: 800-LUNGUSA |
| www.lungusa.org |
|
| The American Lung Association web site contains in-depth information on asthma, and includes interactive features to help you and your child control his or her asthma, as well as information on asthma medications, warning signs for asthma, and asthma camps for children. |
|
|
| The American Lung Association is a registered trademark of the American Lung Association. |
|
|
| AccuNeb® (albuterol sulfate) Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). |
 |
| Important Safety Information |
|
| In a clinical trial with AccuNeb® Inhalation Solution 0.63 mg, AccuNeb® Inhalation Solution 1.25 mg, and placebo, the most commonly reported adverse events were asthma exacerbations (11.1%, 13%, 8.5%), otitis media (0.9%, 4.3%, 0%), allergic reaction (3.4%, 0.9%, 1.7%), gastroenteritis (3.4%, 0.9%, 0.9%), and flu syndrome (2.6%, 2.6%, 1.7%). |
|
| Like other beta-adrenergic agonists, AccuNeb® Inhalation Solution can produce paradoxical bronchospasm, which may be life-threatening. AccuNeb® Inhalation Solution should be used with caution in patients with cardiovascular disorders and patients being treated with epinephrine, oral sympathomimetics, beta-blockers, MAOIs, or tricyclic antidepressants. |
|
| Please see Patient Prescribing Information. |
|
|
|
